Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
57
KAI Quote, Financials, Valuation and Earnings
Last price:
$335.27
Seasonality move
:
2.54%
Day range:
$325.27 - $336.00
52-week range:
$281.30 - $429.95
Dividend yield:
0.49%
P/E ratio:
35.52x
P/S ratio:
3.78x
P/B ratio:
4.50x
Volume:
90.7K
Avg. volume:
123.5K
1-year change:
-1.43%
Market cap:
$3.9B
Revenue:
$1.1B
EPS (TTM):
$9.42
Analysts' Opinion
-
Consensus RatingKadant has received a consensus rating of Hold. The company's average rating is a Hold based on 1 Buy rating, 2 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $335.00, Kadant has an estimated upside of 0.12% from its current price of $334.59.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $275.00 representing 100% downside risk from its current price of $334.59.
Fair Value
-
According to the consensus of 3 analysts, Kadant has 0.12% upside to fair value with a price target of $335.00 per share.
KAI vs. S&P 500
-
Over the past 5 trading days, Kadant has underperformed the S&P 500 by -1.91% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Kadant does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Kadant revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Kadant reported revenues of $239.2M.
Earnings Growth
-
Kadant earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Kadant reported earnings per share of $2.04.
Enterprise value:
4.1B
EV / Invested capital:
--
Price / LTM sales:
3.78x
EV / EBIT:
24.09x
EV / Revenue:
3.96x
PEG ratio (5yr expected):
15.73x
EV / Free cash flow:
30.26x
Price / Operating cash flow:
28.83x
Enterprise value / EBITDA:
18.67x
Gross Profit (TTM):
$465.5M
Return On Assets:
7.68%
Net Income Margin (TTM):
10.63%
Return On Equity:
13.15%
Return On Invested Capital:
9.62%
Operating Margin:
14.88%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $908M | $976.9M | $1B | $249M | $239.2M | |
| Gross Profit | $393.4M | $425.2M | $465.5M | $111M | $110.3M | |
| Operating Income | $156.6M | $163.3M | $170.6M | $36.9M | $35.6M | |
| EBITDA | $190.4M | $201.1M | $221.5M | $49.2M | $48.1M | |
| Diluted EPS | $9.22 | $9.60 | $9.42 | $2.10 | $2.04 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $309.8M | $392.3M | $450.1M | $454.7M | $446.7M | |
| Total Assets | $935.7M | $1.1B | $1.2B | $1.4B | $1.4B | |
| Current Liabilities | $146.6M | $217.6M | $225.8M | $222.1M | $180.6M | |
| Total Liabilities | $431.4M | $544.5M | $484.8M | $614.7M | $548.9M | |
| Total Equity | $504.3M | $599.7M | $684.3M | $794.8M | $886.6M | |
| Total Debt | $222.5M | $247.9M | $181.9M | $310M | $276.9M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $115.7M | $151.5M | $155.3M | $22.8M | $22.8M | |
| Cash From Investing | -$32.7M | -$263.6M | -$85.7M | -$237.3M | -$3.8M | |
| Cash From Financing | -$81.3M | $109.6M | -$56.1M | $192.9M | -$23.1M | |
| Free Cash Flow | $85.9M | $117.9M | $136.7M | $16.6M | $19M | |
KAI
Sector
Market Cap
$3.9B
$609.6M
Price % of 52-Week High
77.82%
81.57%
Dividend Yield
0.49%
0%
Shareholder Yield
-0.51%
2.3%
1-Year Price Total Return
-1.44%
-0.51%
Beta (5-Year)
1.248
0.761
Dividend yield:
0.49%
Annualized payout:
$1.25
Payout ratio:
13.55%
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$328.40
200-day SMA
Sell
Level
$345.11
Bollinger Bands (100)
Buy
Level
303.35 - 348.99
Chaikin Money Flow
Buy
Level
126.9K
20-day SMA
Buy
Level
$320.35
Relative Strength Index (RSI14)
Buy
Level
57.61
ADX Line
Buy
Level
23.59
Williams %R
Neutral
Level
-23.615
50-day SMA
Buy
Level
$317.93
MACD (12, 26)
Buy
Level
90.90
25-day Aroon Oscillator
Buy
Level
48
On Balance Volume
Neutral
Level
358.4K
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (6.4367)
Buy
CA Score
(Annual)
Level (1.0111)
Buy
Beneish M-Score
(Annual)
Level (-2.6192)
Buy
Momentum Score
Level (8)
Buy
Ohlson Score
Level (-1.1332)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (10)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Kadant Inc. supplies process and engineering equipment for papermaking, recycling, lumber manufacturing, and related industries. The company's three reportable segments are the Flow Control segment which consists of the fluid-handling and doctoring, cleaning, & filtration product lines; the Industrial Processing segment which consists of the wood processing and stock-preparation product lines; and Material handling systems, which provides conveyor-belt equipment for industries such as mining, food processing, and packaging. The company has a geographic presence in the U.S., China, Asia, Germany, Canada, and Others.
Stock Forecast FAQ
In the current month, KAI has received 1 Buy ratings 2 Hold ratings, and 0 Sell ratings. The KAI average analyst price target in the past 3 months is $335.00.
-
Where Will Kadant Stock Be In 1 Year?
According to analysts, the consensus estimate is that Kadant share price will rise to $335.00 per share over the next 12 months.
-
What Do Analysts Say About Kadant?
Analysts are divided on their view about Kadant share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Kadant is a Sell and believe this share price will drop from its current level to $275.00.
-
What Is Kadant's Price Target?
The price target for Kadant over the next 1-year time period is forecast to be $335.00 according to 3 Wall Street analysts, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 2 analysts rate the stock a Hold.
-
Is KAI A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Kadant is a Hold. 2 of 3 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of KAI?
You can purchase shares of Kadant via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Kadant shares.
-
What Is The Kadant Share Price Today?
Kadant was last trading at $335.27 per share. This represents the most recent stock quote for Kadant. Yesterday, Kadant closed at $334.59 per share.
-
How To Buy Kadant Stock Online?
In order to purchase Kadant stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
80
SOC alert for Jul 18
Sable Offshore [SOC] is up 5.86% over the past day.
Buy
71
PGY alert for Jul 18
Pagaya Technologies [PGY] is up 4.41% over the past day.
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is down 0.15% over the past day.
